Tratamiento de las enfermedades autoinmunes sist?micas. Glucocorticoides e inmunodepresores

Fl?rez, 1992, Esteroides corticales y antiinflamat?rios esteroideos Villa, 2002 Chatham, 2001, Treatment of lupus with corticosteroids, Lupus, 10, 140, 10.1191/096120301675075008 Kimberly, 1988, Systemic lupus erythematosus. Treatment. Corticosteroids and anti-inflammatory drugs, Rheum Dis Clin North Am, 14, 203, 10.1016/S0889-857X(21)00955-8 Powell, 1972, Corticosteroids in liver disease: studies on the biological conversion of prednisone to prednisolone and plasma binding protein, Gut, 13, 690, 10.1136/gut.13.9.690 Chan, 1978, Steroid hormon action: recent advances, Ann Intern Med, 89, 694, 10.7326/0003-4819-89-5-694 Parrijo, 1979, Mechanism of glucocorticoid action on immune processes, Ann Rev Pharmacol Toxicol, 19, 179, 10.1146/annurev.pa.19.040179.001143 Ballow, 1973, Glucocorticoid supression of macrophage migration inhibitory factor, J Exp Med, 137, 1031, 10.1084/jem.137.4.1031 Guyre, 1988, Glucocorticoid effects on the production and actions of immune cytokines, J Steroid Biochem, 30, 89, 10.1016/0022-4731(88)90080-5 Gillis, 1979, Glucocorticoid induced inhibition of T-cell growth factor, J Immunol, 123, 1632, 10.4049/jimmunol.123.4.1632 Buttgerereit, 2004, Glucocorticoids in the treatment of rheumatic diseases, Arthritis and Rheum, 11, 3408, 10.1002/art.20583 Gottilicher, 1998, Transcriptional cross-talk, the second mode of steroid hormone receptor action, J Mol Med, 76, 480, 10.1007/s001090050242 Reiss, 1979, Steroids dose sparing: pharmacodinamic responses to single versus divided doses of methylprednisolone in man, J Allergy Clin Immunol, 85, 1058, 10.1016/0091-6749(90)90051-5 Kimberly, 1989, Glucocorticoids, Curr Opin Rheumatol, 92, 10.1097/00002281-198901010-00018 Gallo, 1992, Methylprednisolone pulse therapy as primary management strategy in systemic lupus erythematosus, J Rheumatol, 19, 322 Ting, 2001, Local therapy for cutaneous and systemic lupus erythematosus: practical and theoretical considerations, Lupus, 10, 171, 10.1191/096120301667674688 Zonana-Nacach, 2000, Damage in systemic lupus erythematosus and its association with corticosteroids, Arthritis Rheum, 43, 1801, 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O Ginzler, 1998, Prevention and treatment of adverse effects of corticosteroids in systemic lupus erythematosus, Baillieres Clin Rheumatol, 12, 495, 10.1016/S0950-3579(98)80032-0 Salem, 1994, Perioperative glucocorticoid coverage: a reassessment by after emergence of a problem, Ann Surg, 219, 416, 10.1097/00000658-199404000-00013 Ginzler, 1978, Computer analisis of factors influencing frequency of infection in systemic lupus erythematosus, Arthritis Rheum, 21, 37, 10.1002/art.1780210107 Noel, 2001, Risk factors and prognostic influence of infection in single cohort of 87 adults with systemic lupus erythematosus, Ann Rheum Dis, 60, 1141, 10.1136/ard.60.12.1141 Canalis, 2001, Glucocorticoid-induced osteoporosis: summary of a workshop, J Clin Endocrinol Metab, 86, 5681, 10.1210/jc.86.12.5681 Cunnane, 2000, Steroid-induced osteoporosis in systemic lupus erythematosus, Rheum Dis Clin North Am, 26, 311, 10.1016/S0889-857X(05)70140-X Adachi, 1993, Corticosteroid-induced osteoporosis, Semin Artritis Rheum, 22, 375, 10.1016/S0049-0172(05)80029-0 Gonzalez, 1992, Enfermedades ?seas 2001, Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis, Arthritis Rheum, 44, 1496, 10.1002/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5 Olbricht, 1993, Glucocorticoid-induced osteoporosis: pathogenesis, prevention and treatment, with special regard to the rheumatic diseases, J Int Med, 234, 237, 10.1111/j.1365-2796.1993.tb00738.x Saag, 1998, Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocortocoid-Induced Osteoporosis Intervention Study Group, N Engl J Med, 339, 292, 10.1056/NEJM199807303390502 Dougherty, 2002, Risedronate for the prevention and treatment of corticosteroid-induced osteoporosis, Ann Pharmacother, 36, 512, 10.1345/aph.1A114 2000, Targeted tuberculin testing and treatment of latent tuberculosis infection, MMWR Recomm Rep, 49, 1 1999, Med Clin (Barc), 113, 710 Kovacs, 2000, Prophilaxis against opportunistict infections in patients with human immunodeficiency virus infection, N Engl J Med, 342, 1416, 10.1056/NEJM200005113421907 Porges, 1992, Patients with systemic lupus erythematosus at risk for Pneumocystis carinii pneumonia, J Rheumatol, 19, 91 Petri, 1994, Systemic lupus erythematosus and pregnancy, Rheum Clin Dis North Am, 20, 87, 10.1016/S0889-857X(21)00227-1 Turner, 1980, Management of the pregnant asthmatic patient, Ann Intern Med, 6, 905, 10.7326/0003-4819-93-6-905 Roubenoff, 1988, Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility, Sem Arthritis Rheum, 18, 88, 10.1016/0049-0172(88)90002-9 Cote, 1974, Effects on the neonate of prednisone and azatioprine administered to the mother during pregnancy, J Pediatr, 85, 324, 10.1016/S0022-3476(74)80109-5 Stjernholm, 1975, Effects of diphenylhydantoin, Phenobarbital and diazepam on the metabolism of methylprednisolone and its sodium succinate, J Clin Endocrinol Metab, 41, 877, 10.1210/jcem-41-5-887 Petri, 2004, Cyclophosphamide: new approaches for systemic lupus erythematosus, Lupus, 13, 366, 10.1191/0961203303lu1028oa Strange, 2004, Interstitial lung disease in the patients who has connective tissue disease, Clin Chest Med, 25, 549, 10.1016/j.ccm.2004.05.009 Mercadal, 2004, Lupus nephitis: a review of the current pharmacological treatments, Expert Opin Pharmacother, 5, 2263, 10.1517/14656566.5.11.2263